ExAblate
Showing 1 - 25 of 118
Recurrent Glioblastoma Trial in Houston (Pembrolizumab, Exablate MRgFUS + neoadjuvant pembolizumab)
Not yet recruiting
- Recurrent Glioblastoma
- Pembrolizumab
- Exablate MRgFUS + neoadjuvant pembolizumab
-
Houston, TexasM D Anderson Cancer Center
May 18, 2023
Peripheral Neuropathy, Neuropathic Pain Trial in Messina (Exablate treatment)
Completed
- Peripheral Neuropathy
- Neuropathic Pain
- Exablate treatment
-
Messina, ItalyIRCCS Centro Neurolesi "Bonino-Pulejo"
Mar 27, 2023
Brain Tumor Trial in Washington (Exablate, Doxorubicin)
Recruiting
- Brain Tumor
- Exablate
- Doxorubicin
-
Washington, District of ColumbiaChildren's National Medical Center
Jan 4, 2023
Brain Tumor Trial in Toronto (Exablate, Doxorubicin)
Recruiting
- Brain Tumor
- Exablate
- Doxorubicin
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jan 5, 2023
OCD Trial in Palo Alto, Boston (ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy)
Not yet recruiting
- Obsessive-Compulsive Disorder
- ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy
-
Palo Alto, California
- +1 more
Nov 15, 2023
Trigeminal Neuropathic Pain Trial in Charlottesville (Transcranial ExAblate, Sham Transcranial ExAblate)
Active, not recruiting
- Trigeminal Neuropathic Pain
- Transcranial ExAblate
- Sham Transcranial ExAblate
-
Charlottesville, VirginiaUniversity of Virginia
Dec 19, 2022
Recurrent GBM Trial (SONALA-001 (ALA) and Exablate device)
Recruiting
- Recurrent GBM
- SONALA-001 (ALA) and Exablate device
-
Phoenix, Arizona
- +2 more
Jan 6, 2023
Essential Tremor Trial in Móstoles, London (ExAblate)
Recruiting
- Essential Tremor
- ExAblate
-
Móstoles, Madrid, Spain
- +1 more
Dec 19, 2022
Parkinson's Disease Trial in Charlottesville (ExAblate Transcranial System)
Active, not recruiting
- Parkinson's Disease
- ExAblate Transcranial System
-
Charlottesville, VirginiaUniversity of Virginia
Dec 19, 2022
Glioma Trial in Baltimore (ExAblate 4000 - Type 2)
Suspended
- Glioma
- ExAblate 4000 - Type 2
-
Baltimore, MarylandUniversity of Maryland Medical System
Aug 1, 2022
Glioblastoma Multiforme Trial (5-Aminolevulinic Acid)
Not yet recruiting
- Glioblastoma Multiforme
- 5-Aminolevulinic Acid
- (no location specified)
Jan 16, 2023
Essential Tremor Trial in United States (Transcranial ExAblate)
Active, not recruiting
- Essential Tremor
- Transcranial ExAblate
-
Stanford, California
- +6 more
Dec 19, 2022
Parkinson Disease Trial in Móstoles (Exablate Subthalamotomy, Sham Exablate Subthalamotomy)
Active, not recruiting
- Parkinson Disease
- Exablate Subthalamotomy
- Sham Exablate Subthalamotomy
-
Móstoles, Madrid, SpainHospital Universitario HM Puerta Del Sur. CINAC
Aug 2, 2022
Uterine Fibroid Trial in China, United States (Body System - Functional)
Recruiting
- Uterine Fibroid
- Body System - Functional
-
Los Angeles, California
- +3 more
May 18, 2022
Pancreatic Adenocarcinoma Trial in Stanford (ExAblate 2100)
Active, not recruiting
- Pancreatic Adenocarcinoma
- ExAblate 2100
-
Stanford, CaliforniaStanford Cancer Center
Oct 25, 2022
Glioma, Glioblastoma Trial in United States (Focused ultrasound (FUS))
Active, not recruiting
- Glioma
- Glioblastoma
- Focused ultrasound (FUS)
-
Baltimore, Maryland
- +3 more
Sep 8, 2022
Diffuse Intrinsic Pontine Glioma Trial in Phoenix, San Francisco, Washington (SONALA-001 (ALA) and MR-Guided Focused Ultrasound
Recruiting
- Diffuse Intrinsic Pontine Glioma
- SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
-
Phoenix, Arizona
- +2 more
Jan 4, 2023
Benign Centrally-Located Intracranial Tumors Trial in Washington, Miami (ExAblate 4000 System)
Recruiting
- Benign Centrally-Located Intracranial Tumors
- ExAblate 4000 System
-
Washington, District of Columbia
- +1 more
Aug 16, 2022
Brain Tumor Trial (Blood Brain Barrier Disruption - Oncology, Pembrolizumab)
Recruiting
- Brain Tumor
- Blood Brain Barrier Disruption - Oncology
- Pembrolizumab
-
Phoenix, Arizona
- +3 more
Nov 4, 2022
Movement Disorders, Neurology, Parkinsons Disease Trial (Exablate Pallidotomy, Unilateral)
Not yet recruiting
- Movement Disorders
- +2 more
- Exablate Pallidotomy, Unilateral
- (no location specified)
Sep 13, 2022
Mild Cognitive Impairment, Alzheimer 1 Trial in Morgantown (Aducanumab, Exablate Model 4000 Type 2)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease 1
- Aducanumab
- Exablate Model 4000 Type 2
-
Morgantown, West VirginiaWest Virginia University Rockefeller Neuroscience Institute
Jul 19, 2022
Essential Tremor, Neurology Trial (Exablate Neuro Type 1.0 System with Echo Focusing)
Not yet recruiting
- Essential Tremor
- Neurology
- Exablate Neuro Type 1.0 System with Echo Focusing
- (no location specified)
Aug 3, 2022
Essential Tremor Trial in Worldwide (Transcranial ExAblate, Sham Transcranial ExAblate)
Active, not recruiting
- Essential Tremor
- Transcranial ExAblate
- Sham Transcranial ExAblate
-
Stanford, California
- +7 more
Mar 29, 2022
Opioid-use Disorder Trial in Morgantown (Exablate Model 4000 Type 2.0/2.1)
Active, not recruiting
- Opioid-use Disorder
- Exablate Model 4000 Type 2.0/2.1
-
Morgantown, VirginiaWest Virginia University: Rockefeller Neuroscience Institute
Mar 28, 2022
Movement Disorders, Essential Tremor, Holmes Tremor Trial in Toronto (Transcranial ExAblate System)
Active, not recruiting
- Movement Disorders
- +8 more
- Transcranial ExAblate System
-
Toronto, Ontario, Canada
- +1 more
Dec 19, 2022